Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Lodrini

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Cancers|May 14, 2022
Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular DiagnosticsMarco Lodrini, Jasmin Wünschel, Theresa M Thole-Kliesch, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
Histone deacetylase 10 promotes autophagy-mediated cell survivalIna Oehme, Jan-Peter Linke, Barbara C Böck, et al.
Cancers|February 13, 2026
YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma CellsMarius Ludwig, Kerstin Ahrens, Annika Winkler, et al.
International Journal of Cancer|July 16, 2019
Reflection of neuroblastoma intratumor heterogeneity in the new OHC-NB1 disease modelTheresa M Thole, Joern Toedling, Annika Sprüssel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with NeuroblastomaMarco Lodrini, Josefine Graef, Theresa M Thole-Kliesch, et al.
Acta Neuropathologica|August 25, 2011
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor VorinostatTill Milde, Susanne Kleber, Andrey Korshunov, et al.
Cancer Research Communications|January 6, 2025
Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with NeuroblastomaJan F Hollander, Annabell Szymansky, Jasmin Wünschel, et al.
Pharmacological Research|January 19, 2025
Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacyLaura Grunewald, Lena Andersch, Konstantin Helmsauer, et al.
Cancer Research|January 15, 2014
GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3Johannes Fabian, Marco Lodrini, Ina Oehme, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Cryo-mtscATAC-seq for single-cell mitochondrial DNA genotyping and clonal tracing in archived human tissuesMaren Salla, Benedikt Obermayer, Marie Cotta, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Cancers|May 14, 2022
Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular DiagnosticsMarco Lodrini, Jasmin Wünschel, Theresa M Thole-Kliesch, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
Histone deacetylase 10 promotes autophagy-mediated cell survivalIna Oehme, Jan-Peter Linke, Barbara C Böck, et al.
Cancers|February 13, 2026
YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma CellsMarius Ludwig, Kerstin Ahrens, Annika Winkler, et al.
International Journal of Cancer|July 16, 2019
Reflection of neuroblastoma intratumor heterogeneity in the new OHC-NB1 disease modelTheresa M Thole, Joern Toedling, Annika Sprüssel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with NeuroblastomaMarco Lodrini, Josefine Graef, Theresa M Thole-Kliesch, et al.
Acta Neuropathologica|August 25, 2011
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor VorinostatTill Milde, Susanne Kleber, Andrey Korshunov, et al.
Cancer Research Communications|January 6, 2025
Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with NeuroblastomaJan F Hollander, Annabell Szymansky, Jasmin Wünschel, et al.
Pharmacological Research|January 19, 2025
Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacyLaura Grunewald, Lena Andersch, Konstantin Helmsauer, et al.
Cancer Research|January 15, 2014
GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3Johannes Fabian, Marco Lodrini, Ina Oehme, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Cryo-mtscATAC-seq for single-cell mitochondrial DNA genotyping and clonal tracing in archived human tissuesMaren Salla, Benedikt Obermayer, Marie Cotta, et al.
Pageof 4